This site is intended for healthcare professionals only

New An in-depth review discussing two posters presented at ESC 2019

With

Professor Søren Paaske Johnsen

With

Professor Daniele Pastori

Approx. time required 60 mins
Watch now

Upcoming Bleeding and New Cancer Diagnosis in Patients with Atherosclerosis: COMPASS Trial

With

Professor John Eikelboom

Approx. time required N/A
Attend live

New Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

With

Dr Stuart Connolly

Approx. time required 30 mins
Watch now

Betrixaban versus enoxaparin for VTE in critically ill patients: an APEX substudy

With

Dr Russell Hull

Approx. time required 30 mins
Watch now

Two of the questions asked most often are which NOAC to take for which patient, and what's the relevance and clinical role of NOAC antidotes. Thus, there is still much more room and necessity for high-level and independent medical education in this field.

Professor Dr Harald Darius, NOAC faculty member